Management ChangeApr 30, 2026, 05:23 PM
HCAT Appoints New CEO, Multiple Exec Changes, Board Updates
AI Summary
Health Catalyst, Inc. filed an Amendment No. 1 to its 2024 Form 10-K to include detailed information on directors, executive officers, corporate governance, executive compensation, and related matters. The company announced significant leadership changes, including the appointment of Benjamin Albert as CEO, the retirement of Daniel Burton, and the departures of other key executives. The Board also saw new appointments and a non-renomination. The filing also outlined updates to the executive compensation program for fiscal years 2025 and 2026, including a shift in the 2026 bonus plan to 100% cash.
Key Highlights
- Benjamin Albert appointed CEO effective February 12, 2026.
- Daniel Burton retired as CEO effective February 12, 2026.
- Kevin Freeman ceased as Chief Commercial Officer effective February 1, 2026.
- Dan LeSueur ceased as COO effective September 15, 2025.
- Linda Llewelyn to cease as Chief People Officer effective June 1, 2026.
- Steven Nelson appointed to Board of Directors effective May 1, 2026.
- Matthew Kolb will not be renominated for the 2026 annual meeting.
- 2026 Bonus Plan shifts to 100% cash from 2025's 100% PRSUs.